Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-21-005635
Filing Date
2021-08-16
Accepted
2021-08-16 17:17:15
Documents
117
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm   iXBRL 10-Q 1489944
2 CERTIFICATION curr_ex311.htm EX-31.1 9470
3 CERTIFICATION curr_ex312.htm EX-31.2 10300
4 CERTIFICATION curr_ex321.htm EX-32.1 4158
5 CERTIFICATION curr_ex322.htm EX-32.2 4077
  Complete submission text file 0001477932-21-005635.txt   9442710

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA curr-20210630.xsd EX-101.SCH 125251
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20210630_lab.xml EX-101.LAB 593732
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20210630_cal.xml EX-101.CAL 85369
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20210630_pre.xml EX-101.PRE 528036
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20210630_def.xml EX-101.DEF 321767
11 EXTRACTED XBRL INSTANCE DOCUMENT curr_10q_htm.xml XML 1765975
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 211179828
SIC: 2834 Pharmaceutical Preparations